Antibiotic resistance: Phages to the rescue?
The crisis caused by antimicrobial resistance is growing worse, and in the search for solutions, it makes sense to take a closer look at an alternative that’s already out there – bacteriophages. They’ve been used in Eastern Europe for decades. Now pressure is mounting on global health authorities to see whether bacteria-killing viruses or products based on them could provide a viable option to antibiotics. But guidelines are lacking in Western countries, and many doctors remain cautious about the idea of treating infections with viruses.
In this issue:
- Genome editing: EU Court’s Advocate General disappoints GM opponents
- Immunology: How fast food corrupts your immune system permanently
- Big Bioindustry: Attracting investment to scale up bio-based production
- GMP bioproduction: Which CDMOs will seize the lead in an expanding market?
- Interview with Aleks Engel, Partner at Novo Holdings, and George Griffin, Chair of the SAB of the REPAIR impact fund
- News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA and the Swiss Biotech Association
Industry criticises EPO plans
Concerns raised by life sciences stakeholders regarding the European Patent Office’s Early Certainty in Examination project can no longer be...
Microfluidics: Mapping DNA-binders
A patent on microfluidics-based ligand enrichment followed by sequencing has been filed, and the group, headed by Bart Deplancke, aims to...
A clear path ahead for the bioeconomy
European Biotechnology Matti, you say we need to stop using fossil fuels. But right now there hardly seems to be a consensus on that –...